You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Avapritinib

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

Recruiting
  • Core Binding Factor Acute Myeloid Leukemia
  • KIT Mutation-Related Tumors
  • Avapritinib
  • Suzhou, Jiangsu, China
    First Affiliated Hospital of Soochow University
Apr 7, 2023

Avapritinib in Chinese Gastrointestinal Stromal Tumor in Real

Recruiting
  • Gastrointestinal Stromal Tumors
  • Avapritinib
  • Tyrosine kinase inhibitors other than avapritinib ( imatinib, sunitinib, et al )
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Sep 14, 2022

Gastrointestinal Stromal Tumors, GIST Trial (Avapritinib, midazolam)

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • GIST
  • (no location specified)
Jul 20, 2022

Gastrointestinal Stromal Tumors Trial in Villejuif (Avapritinib)

Active, not recruiting
  • Gastrointestinal Stromal Tumors
  • Avapritinib
  • Villejuif, Val-de-Marne, France
    Gustave Roussy Cancer Campus Grand Paris Institut de Cancerologi
May 16, 2022

Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematological Tumor

Approved for marketing
  • Advanced Systemic Mastocytosis
  • +3 more
  • Avapritinib
  • (no location specified)
Oct 5, 2021

Solid Tumor, Unspecified, Child, Relapsed Solid Tumor, CNS Tumor Trial in Worldwide (avapritinib)

Recruiting
  • Solid Tumor, Unspecified, Child
  • +2 more
  • avapritinib
  • Phoenix, Arizona
  • +12 more
Jul 19, 2022

Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations

Not yet recruiting
  • Gastrointestinal Stromal Tumors
  • +2 more
    • (no location specified)
    Jul 15, 2022

    Metastatic or Unresectable Gastrointestinal Stromal Tumors

    Not yet recruiting
    • Gastrointestinal Stromal Tumors
    • +2 more
      • (no location specified)
      Jul 16, 2022

      Avapritinib Versus Best Available Therapy in Patients With AdvSM

      Completed
      • Advanced Systemic Mastocytosis
      • +3 more
        • Palo Alto, California
        • +5 more
        Dec 17, 2021

        Gastrointestinal Stromal Tumors Trial in Beijing, Guangzhou (CS3007 (BLU-285))

        Active, not recruiting
        • Gastrointestinal Stromal Tumors
        • CS3007 (BLU-285)
        • Beijing, Beijing, China
        • +1 more
        Apr 25, 2022

        GIST, GIST, Malignant, PDGFR-Alpha D842V Trial in France (Patient treated by Avapritinib in real life)

        Recruiting
        • GIST
        • +2 more
        • Patient treated by Avapritinib in real life
        • Besançon, France
        • +5 more
        Jun 9, 2021

        Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial

        Completed
        • Aggressive Systemic Mastocytosis
        • +3 more
        • Avapritinib
        • Stanford, California
        • +10 more
        Jan 12, 2023

        Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematologic Tumor

        Active, not recruiting
        • Advanced Systemic Mastocytosis
        • +3 more
        • Avapritinib
        • Stanford, California
        • +31 more
        Mar 25, 2022

        GIST Trial (Avapritinib)

        Approved for marketing
        • GIST
        • Avapritinib
        • (no location specified)
        Jul 23, 2020

        Indolent Systemic Mastocytosis Trial in Worldwide (Avapritinib, Placebo)

        Active, not recruiting
        • Indolent Systemic Mastocytosis
        • Avapritinib
        • Placebo
        • Birmingham, Alabama
        • +48 more
        Jan 19, 2022

        Gastrointestinal Stromal Tumors (GIST), Other Relapsed or Refractory Solid Tumors Trial in Worldwide (Avapritinib)

        Completed
        Has Results
        • Gastrointestinal Stromal Tumors (GIST)
        • Other Relapsed or Refractory Solid Tumors
        • Avapritinib
        • Scottsdale, Arizona
        • +18 more
        May 20, 2022

        Soft Tissue Sarcoma Adult Trial in Lake Success, Portland, Seattle (Multiple drug microinjection, CIVO device)

        Completed
        • Soft Tissue Sarcoma Adult
        • Multiple drug microinjection
        • CIVO device
        • Lake Success, New York
        • +2 more
        Sep 22, 2021

        GIST Trial in Worldwide (avapritinib, regorafenib)

        Completed
        Has Results
        • GIST
        • Phoenix, Arizona
        • +113 more
        Sep 9, 2022